SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Bluegreen who wrote (7841)11/25/1998 8:29:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Something to be thankful for:

1.
5,837,678 Therapeutic uses of bactericidal/permeability increasing protein products
2.
5,837,491 Polynucleotides encoding gelonin sequences
3.
5,827,816 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions
containing the same
4.
5,821,123 Modified antibody variable domains
5.
5,821,064 Method of screening for an active inflammatory state by determining the concentration of
extracellular BPI
6.
5,807,818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products
7.
5,804,367 Method for quantifying LBP in body fluids
8.
5,783,561 Anti-gram-positive bacterial methods and materials
9.
5,770,561 Method for potentiating BPI protein product bactericidal activity by administration of LBP protein
products
10.
5,770,196 Modified antibody variable domains and therapeutic uses thereof
11.
5,766,886 Modified antibody variable domains
12.
5,763,567 Biologically active peptides from funcional domains of bactericidal/permeability-increasing protein
and uses thereof
13.
5,756,699 Immunotoxins comprising ribosome-inactivating proteins
14.
5,756,464 Therapeutic uses of BPI protein products in humans with hemmorhage due to trauma
15.
5,753,620 Human therapeutic uses of BPI protein products
16.
5,744,580 Immunotoxins comprising ribosome-inactivating proteins
17.
5,741,779 Antithrombotic materials and methods
18.
5,733,872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein
and uses thereof
19.
5,731,415 Lipopolysaccharide binding protein derivatives
20.
5,721,108 Chimeric antibody with specificity to human B cell surface antigen
21.
5,703,038 Therapeutic uses of bactericidal-permeability-increasing protein dimer products
22.
5,698,435 Modular assembly of antibody genes, antibodies prepared thereby and use
23.
5,698,417 Modular assembly of antibody genes, antibodies prepared thereby and use
24.
5,696,090 Pharmaceutical composition
25.
5,693,493 Modular assembly of antibody genes, antibodies prepared thereby and use
26.
5,686,414 Methods of treating conditions associated with corneal transplantation
27.
5,677,180 Chimeric antibody with specificity to human B cell surface antigen
28.
5,674,834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions
containing the same
29.
5,652,332 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein
and uses thereof
30.
5,646,114 Anti-protozoan methods
31.
5,643,570 BPI-immunoglobulin fusion proteins
32.
5,639,727 Therapeutic uses of bactericidal/permeability increasing protein products
33.
5,627,153 Anti-fungal methods and materials
34.
5,621,083 Immunotoxins comprising ribosome-inactivating proteins
35.
5,618,920 Modular assembly of antibody genes, antibodies prepared thereby and use
36.
5,595,898 Modular assembly of antibody genes, antibodies prepared thereby and use